With the departure of Astellas and now Biogen Idec, Aveo Oncology is fresh out of collaborators, sending the struggling biotech back to the partnering table as it looks to advance an early-stage cancer drug.

…read more

Source: Partnerless Aveo is back on the hunt as Biogen returns a cancer drug


0 No comments